Valuation Brooks Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. 06:02:25 2026-10-15 EDT			5-day change	1st Jan Change
70.40 ^INR	+2.40%		-0.09%	-12.27%

09-16	Brooks Laboratories Limited Announces Resignation of Krutika Rane as Company Secretary and Compliance Officer (Key Managerial Personnel), Effective October 9, 2026	CI
08-13	Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	1,514	1,801	1,540	2,457	3,167	1,093
Change	-	18.92%	-14.47%	59.5%	28.93%	-65.49%
Enterprise Value (EV) ¹	1,919	2,027	1,605	2,512	3,243	1,112
Change	-	5.63%	-20.83%	56.49%	29.1%	-65.72%
P/E	-7.82x	-11.1x	-7.37x	-12.2x	-28.6x	4.45x
PBR	1.91x	2.86x	2.08x	3.75x	3.19x	0.89x
PEG	-	0.7x	-0.3x	1.27x	0.6x	-0x
Capitalization / Revenue	1.95x	1.98x	2.44x	3.09x	3.84x	1.27x
EV / Revenue	2.47x	2.23x	2.54x	3.16x	3.93x	1.3x
EV / EBITDA	219x	-13.9x	-6x	70.2x	65.6x	15.3x
EV / EBIT	-32x	-9.38x	-4.81x	120x	88.1x	18.4x
EV / FCF	-20.4x	-4.22x	18.2x	-23.9x	-203x	37.1x
FCF Yield	-4.9%	-23.7%	5.49%	-4.18%	-0.49%	2.69%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-7.843	-6.553	-8.461	-7.648	-3.72	8.346
Distribution rate	-	-	-	-	-	-
Net sales ¹	778.1	910.8	632	794.9	825.6	857.4
EBITDA ¹	8.783	-145.4	-267.4	35.77	49.45	72.65
EBIT ¹	-60.03	-216	-334	20.94	36.8	60.26
Net income ¹	-193.8	-161.9	-209	-195.9	-99.67	245.8
Net Debt ¹	405	226.5	64.89	55.16	75.39	18.44
Reference price ²	61.30	72.90	62.35	93.60	106.36	37.11
Nbr of stocks (in thousands)	24,703	24,703	24,703	26,247	29,780	29,457
Announcement Date	9/7/21	9/6/22	8/30/23	8/28/24	9/4/25	8/12/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,077B
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	612B
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	364B
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	353B
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	278B
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	251B
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	230B
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	190B
Average	29.54x	6.82x	18.14x	2.19%	428.5B
Weighted average by Cap.	35.12x	7.99x	19.65x	1.87%